Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Expert Reviews in Molecular Medicine
ISSN 1462-3994 · Cambridge University Press · ENGLAND · Irregular · Founded 1997
Expert Reviews in Molecular Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.38; fully open access; APC about USD 3,655; community-reported acceptance: fairly hard; 37 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Expert Reviews in Molecular Medicine is published by Cambridge University Press and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Epigenetics and DNA Methylation, Immunotherapy and Immune Responses and RNA Interference and Gene Delivery, together about 19.4% of its articles. Its main subfields are Molecular Biology and Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Nicola Curtin Editorial BoardExpert Reviews in Molecular Medicine is a gold open access journal featuring authoritative and timely reviews on all aspects of molecular medicine. Review articles cover current and emerging understanding of the molecular mechanisms underpinning human health and disease, and molecular aspects of the approaches used to diagnose and treat them. They may critically evaluate laboratory or in silico studies, studies on patient samples and molecular aspects of clinical diagnostics or therapy. The journal's focus is on translation from molecular science to clinical studies and is not constrained to any single system or disease. We particularly welcome articles spanning more than one of the themes below. Overarching Themes:Molecular mechanisms of disease, including hereditary disordersMolecular aspects of infection, immunity and inflammationDiagnostic, prognostic and predictive molecular biomarkersMolecular mechanisms of all classes of therapeutic agents, including novel and repurposed drugs, biologics, immunotherapeuticsNovel molecular technologiesBioinformatics.Within these themes topics may be disease-specific. While we welcome papers covering all traditional specialist disease areas, we are also extremely interested in general cross cutting areas, including life-course diseases (in utero to ageing).
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Nicola CurtinPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology7.5%
- Immunotherapy and Immune ResponsesImmunology and Microbiology6%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology6%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5.7%
- Immune Cell Function and InteractionImmunology and Microbiology5.1%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.6%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4.4%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.38LetPub ·
- Impact factor (publisher) 2025
- 54Publisher website ·
- CiteScore 2026-06
- 9.9LetPub ·
- SJR 2026-06
- 1.69LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 73LetPub ·
- h-index
- 113OpenAlex ·
- i10-index
- 597OpenAlex ·
- 2-year mean citedness
- 7.24OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 87.5%LetPub ·
Volume
- Articles per year
- 35LetPub ·
Articles by year OpenAlex count · 730 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 43 |
| 2025 | 37 | 37 | 305 |
| 2024 | 36 | 36 | 477 |
| 2023 | 26 | 16 | 569 |
| 2022 | 48 | 25 | 1,189 |
| 2021 | 25 | 12 | 857 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,655 / GBP 2,610 | Yes | CC BY, CC BY-NC-SA, CC BY-NC-ND | |
| OpenAlex | USD 3,550 / GBP 2,460 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- reviewWe accept the following types of articles: Review* Short Review* Systematic Review*Length not stated
- short reviewWe accept the following types of articles: Review* Short Review* Systematic Review*Length not stated
- systematic reviewWe accept the following types of articles: Review* Short Review* Systematic Review*Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Cambridge University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Irregular
- Founded
- 1997
- ISSN
- 1462-3994
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Expert Reviews in Molecular Medicine
What CAS zone is Expert Reviews in Molecular Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Expert Reviews in Molecular Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Biochemistry & Molecular Biology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Expert Reviews in Molecular Medicine?
The latest impact factor listed by LetPub is 6.38; CiteScore 9.9, h-index 113.
Which databases index Expert Reviews in Molecular Medicine?
According to LetPub and DOAJ records, Expert Reviews in Molecular Medicine is indexed in SCIE, Scopus and DOAJ.
Is Expert Reviews in Molecular Medicine open access, and what is the APC?
Expert Reviews in Molecular Medicine is a fully open-access journal. APC about USD 3,655.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .